https://www.selleckchem.com/pr....oducts/z-4-hydroxyta
The cost of implementation was calculated based on the time screening required from nursing and social work. Review of the program focused on implementation fidelity, quality improvement, and trends among screening results. During the first year of screening, 138,598 screens were completed, and 6.8% of screens were positive for elevated risk. The annualized cost of the program was estimated to be $887,708.65 for personnel directly involved in screening and following up on positive screens. Early involvement of stakeholders